EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma

Raymond Ho, Jason C Mills

Journal of Clinical Investigation · 01.07.2026 · 136 (13)

DOI: 10.1172/jci207473 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.07.2026. Verfasst von Raymond Ho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Lung Neoplasms, Adenocarcinoma, Cell Plasticity. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cells use plasticity programs to change lineages, which aids in tissue regeneration and remodeling but also allows aberrant cells to become cancerous and escape therapy. For example, tumor cells in invasive mucinous adenocarcinoma (IMA) emerge from lung epithelial cells by a plasticity program that reprograms them into gastric epithelium–like cells. In this issue of the JCI , Dadzie et al. show that hepatocyte nuclear factor 4 α (HNF4α) promotes gastric identity in lung epithelial cells via a mechanism involving restriction of FOXA1 and FOXA2 transcription factors to gastric gene enhancer loci. HNF4α also promotes resistance to KRAS inhibition by increasing nuclear factor erythroid 2–related factor 2 (NRF2) activity. These findings may advance therapeutic avenues in IMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4Lung NeoplasmsAdenocarcinomaCell PlasticityHumansAnimalsNF-E2-Related Factor 2Adenocarcinoma of LungHepatocyte Nuclear Factor 3-betaProto-Oncogene Proteins p21(ras)

Substanzen

Hepatocyte Nuclear Factor 4NF-E2-Related Factor 2HNF4A protein, humanHepatocyte Nuclear Factor 3-betaNFE2L2 protein, humanFOXA2 protein, humanProto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  • Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.

Zitieren

APA

Ho, R., & Mills, J. C. (2026). Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma. Journal of Clinical Investigation, 136(13). https://doi.org/10.1172/jci207473

Vancouver

Ho R, Mills JC. Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma. Journal of Clinical Investigation. 2026;136(13). doi:10.1172/jci207473

BibTeX
@article{Ho2026,
  author = {Ho, Raymond and Mills, Jason C},
  title = {Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {13},
  doi = {10.1172/jci207473}
}
Kostenlos starten →